Menu Search
Equities

Chill Brands Group PLC

CHLL:LSE

Chill Brands Group PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2.15
  • Today's Change0.00 / 0.00%
  • Shares traded3.74m
  • 1 Year change-56.12%
  • Beta1.0987
Data delayed at least 20 minutes, as of May 31 2024 17:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chill Brands Group PLC is a United Kingdom-based consumer packaged-goods distribution company. The Company is involved in the sale and distribution of premium cannabidiol (CBD) products and vapor products. It is also focused on the development of an e-commerce marketplace for wellness and recreational products made with natural, functional ingredients including cannabinoids, hemp derivatives and others. The Company develops, markets and distributes its own range of nicotine-free vapor products under the CHILLZER0 brand. Chill is a CBD brand of tobacco alternative products, including smoke and chew pouches. Under the Zoetic brand, the Company offers CBD-infused topical creams, beauty products and ingestible tinctures in the UK. Sales are made both through a network of retail stores in the United States and UK, but also via the Chill.com Website. Zoetic offers oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products.

  • Revenue in GBP (TTM)146.62k
  • Net income in GBP-3.64m
  • Incorporated2014
  • Employees2.00
  • Location
    Chill Brands Group PLCEastcastle House 27/28Eastcastle StreetLONDON W1W 8DHUnited KingdomGBR
  • Phone+44 173 847 2029
  • Websitehttps://chillbrandsgroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.